HK1211498A1 - Treatment of sickle cell disease and inflammatory conditions - Google Patents
Treatment of sickle cell disease and inflammatory conditionsInfo
- Publication number
- HK1211498A1 HK1211498A1 HK15112500.1A HK15112500A HK1211498A1 HK 1211498 A1 HK1211498 A1 HK 1211498A1 HK 15112500 A HK15112500 A HK 15112500A HK 1211498 A1 HK1211498 A1 HK 1211498A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- inflammatory conditions
- sickle cell
- cell disease
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261692567P | 2012-08-23 | 2012-08-23 | |
| US201361842671P | 2013-07-03 | 2013-07-03 | |
| PCT/US2013/056223 WO2014031875A1 (en) | 2012-08-23 | 2013-08-22 | Treatment of sickle cell disease and inflammatory conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1211498A1 true HK1211498A1 (en) | 2016-05-27 |
Family
ID=50150385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15112500.1A HK1211498A1 (en) | 2012-08-23 | 2015-12-18 | Treatment of sickle cell disease and inflammatory conditions |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10350228B2 (xx) |
| EP (1) | EP2887947B1 (xx) |
| CA (1) | CA2882725C (xx) |
| HK (1) | HK1211498A1 (xx) |
| MX (1) | MX363385B (xx) |
| WO (1) | WO2014031875A1 (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2282773B2 (en) | 2008-05-02 | 2025-03-05 | Seagen Inc. | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| CA2803388C (en) | 2010-08-05 | 2019-11-05 | Seattle Genetics, Inc. | Methods of inhibition of protein fucosylation in vivo using fucose analogs |
| WO2014130613A2 (en) | 2013-02-22 | 2014-08-28 | Amgen Inc. | Carbohydrate phosphonate derivatives as modulators of glycosylation |
| JP2018002666A (ja) * | 2016-07-04 | 2018-01-11 | 国立研究開発法人理化学研究所 | フコース類似体と糖を検出する方法 |
| WO2021062238A1 (en) * | 2019-09-27 | 2021-04-01 | The University Of Chicago | Methods and compositions for treating sickle cell disease and thalassemia |
| US12116382B2 (en) | 2022-11-28 | 2024-10-15 | Hongene Biotech Corporation | Functionalized N-acetylgalactosamine analogs |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440780A (en) | 1979-06-01 | 1984-04-03 | Chevron Research Company | Fungicidal 3-(N-acyl-N-arylamino)-and 3-(N-thionoacyl-N-arylamino)-gamma-butyrolactones and gamma-thiobutyrolactones |
| JPH0660189B2 (ja) | 1986-01-22 | 1994-08-10 | 財団法人微生物化学研究会 | ２，６−ジデオキシ−２−フルオロ−ｌ−タロピラノ−ス又はその誘導体とその製造法 |
| FR2630914A1 (fr) | 1988-05-04 | 1989-11-10 | Hoechst Sa Laboratoires | Nouveaux analogues du l-fucose, leur procede de preparation, application de ces analogues a la preparation de nouveaux glycals, anthracyclines obtenues a l'aide de ces glycals et utilisation desdites anthracyclines en tant que medicaments |
| KR100211417B1 (ko) | 1990-11-30 | 1999-10-01 | 유충식 | L-탈로피라노시드 유도체 및 그의 제조방법 |
| US5461143A (en) | 1991-03-18 | 1995-10-24 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| US5210078A (en) | 1991-04-30 | 1993-05-11 | The Biomembrane Institute | Trifluoromethyl analogs of fucose and uses thereof |
| WO1993008205A1 (en) | 1991-10-15 | 1993-04-29 | The Scripps Research Institute | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose |
| EP0721956B1 (en) | 1993-09-29 | 2000-08-02 | Nissin Shokuhin Kabushiki Kaisha | 21-substituted steroid compound |
| FR2723947B1 (fr) | 1994-08-31 | 1996-09-27 | Adir | Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| DE19524515A1 (de) | 1995-07-05 | 1997-01-09 | Deutsches Krebsforsch | Saccharid-Konjugate |
| US6713287B1 (en) | 1995-10-24 | 2004-03-30 | The Scripps Research Institute | Enzymatic synthesis of L-fucose and L-fucose analogs |
| US5770407A (en) | 1996-12-10 | 1998-06-23 | The Scripps Research Institute | Process for preparing nucleotide inhibitors of glycosyltransferases |
| JP4451933B2 (ja) | 1996-12-27 | 2010-04-14 | 住友化学株式会社 | 遺伝子操作による植物へのｐｐｏ阻害性除草剤耐性付与法 |
| US6075134A (en) | 1997-05-15 | 2000-06-13 | The Regents Of The University Of California | Glycoconjugates and methods |
| JPH1135593A (ja) | 1997-07-18 | 1999-02-09 | Daikin Ind Ltd | ２−フルオロフコシル−ｎ−アロイルグルコサミン誘導体及びその中間物、並びにそれらの製造方法 |
| US6670330B1 (en) | 2000-05-01 | 2003-12-30 | Theodore J. Lampidis | Cancer chemotherapy with 2-deoxy-D-glucose |
| US7265084B2 (en) | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| WO2003085118A1 (fr) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Procede de production de composition anticorps |
| BRPI0406667A (pt) | 2003-01-10 | 2005-12-20 | Threshold Pharmaceuticals Inc | Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg |
| CA2522345A1 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7691603B2 (en) | 2003-04-09 | 2010-04-06 | Novo Nordisk A/S | Intracellular formation of peptide conjugates |
| US7332334B2 (en) | 2003-04-18 | 2008-02-19 | Oklahoma Medical Research Foundation | Hematopoietic stem cells treated by in vitro fucosylation and methods of use |
| JPWO2005017155A1 (ja) | 2003-06-18 | 2006-10-12 | 中外製薬株式会社 | フコーストランスポーター |
| AU2004280066A1 (en) | 2003-10-09 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Genomically modified cell |
| KR20060129296A (ko) | 2003-12-23 | 2006-12-15 | 프로젠 인더스트리즈 리미티드 | 글리코사미노글리칸(ｇａｇ) 모방체 |
| DE102004032421A1 (de) | 2004-07-05 | 2006-01-26 | Bayer Cropscience Ag | Phenylsubstituierte [1.2]-Oxazin-3,5-dion-und Dihydropyron-Derivate |
| US7393836B2 (en) | 2004-07-06 | 2008-07-01 | Boehringer Ingelheim International Gmbh | D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| US20090061485A1 (en) | 2004-12-22 | 2009-03-05 | Chugai Seiyaku Kabushiki Kaisha | Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited |
| JP5583908B2 (ja) | 2005-10-21 | 2014-09-03 | ジェンザイム・コーポレーション | 増強されたａｄｃｃ活性を伴う抗体に基づく治療薬 |
| US8278349B2 (en) | 2005-11-28 | 2012-10-02 | Ramot At Tel-Aviv University Ltd. | Cancer treatment using FTS and 2-deoxyglucose |
| CN101400793B (zh) | 2005-12-21 | 2014-06-11 | 维文蒂阿生物技术股份有限公司 | 与癌症相关的新抗原 |
| WO2007081031A1 (ja) | 2006-01-16 | 2007-07-19 | Hokkaido University | 糖転移酵素阻害剤 |
| EP2623986B1 (en) | 2006-02-10 | 2017-06-14 | Life Technologies Corporation | Labeling and detection of post translationally modified proteins |
| EP1991056A4 (en) | 2006-02-24 | 2009-09-02 | Univ Miami | MANNOSEDERIVATES FOR THE KILLING OF TUMOR CELLS |
| JP5885378B2 (ja) | 2006-03-22 | 2016-03-22 | ザ スクリプス リサーチ インスティテュート | グリコペプチドの調製法 |
| WO2009108926A1 (en) | 2008-02-29 | 2009-09-03 | Board Of Regents, The University Of Texas System | Inhibitors of glycolysis useful in the treatment of brain tumors |
| US9149489B2 (en) | 2006-04-27 | 2015-10-06 | Board Of Regents, University Of Texas System | Inhibitors of glycolysis useful in the treatment of brain tumors |
| EP2076538A2 (en) | 2006-10-24 | 2009-07-08 | Trubion Pharmaceuticals, Inc. | Materials and methods for improved immunoglycoproteins |
| CA2677747A1 (en) | 2007-02-09 | 2008-08-21 | Glycomimetics, Inc. | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| WO2008131024A1 (en) | 2007-04-17 | 2008-10-30 | Board Of Regents, The University Of Texas System | Iodo-hexose compounds useful to treat cancer |
| SI2211904T1 (sl) | 2007-10-19 | 2016-12-30 | Seattle Genetics, Inc. | CD19 vezavna sredstva in njihove uporabe |
| US20110003338A1 (en) | 2008-03-11 | 2011-01-06 | Robert Bayer | Antibodies with enhanced adcc function |
| EP2282773B2 (en) | 2008-05-02 | 2025-03-05 | Seagen Inc. | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| WO2009143078A2 (en) | 2008-05-19 | 2009-11-26 | Board Of Regents, The University Of Texas System | Methods of treating brain cancer using hexose compounds |
| CN102065868A (zh) | 2008-06-16 | 2011-05-18 | 中央研究院 | 诱发对于Globo H及SSEA3的特异免疫反应的组合物以及其在癌症治疗中的用途 |
| WO2010111713A2 (en) | 2009-03-27 | 2010-09-30 | Zacharon Pharmaceuticals, Inc. | N-linked glycan biosynthesis modulators |
| US20110288880A1 (en) | 2010-05-07 | 2011-11-24 | Patient Care Automation Services, Inc. | Targeted health care messaging |
| CA2803388C (en) * | 2010-08-05 | 2019-11-05 | Seattle Genetics, Inc. | Methods of inhibition of protein fucosylation in vivo using fucose analogs |
| EP2663314A2 (en) | 2011-01-11 | 2013-11-20 | The University of Texas M.D. Anderson Cancer | Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
-
2013
- 2013-08-22 CA CA2882725A patent/CA2882725C/en active Active
- 2013-08-22 WO PCT/US2013/056223 patent/WO2014031875A1/en active Application Filing
- 2013-08-22 US US14/422,976 patent/US10350228B2/en active Active
- 2013-08-22 MX MX2015002307A patent/MX363385B/es unknown
- 2013-08-22 EP EP13831167.5A patent/EP2887947B1/en active Active
-
2015
- 2015-12-18 HK HK15112500.1A patent/HK1211498A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2882725C (en) | 2021-03-09 |
| US10350228B2 (en) | 2019-07-16 |
| CA2882725A1 (en) | 2014-02-27 |
| US20150238509A1 (en) | 2015-08-27 |
| MX363385B (es) | 2019-03-20 |
| EP2887947A1 (en) | 2015-07-01 |
| EP2887947A4 (en) | 2016-01-06 |
| EP2887947B1 (en) | 2019-06-05 |
| WO2014031875A1 (en) | 2014-02-27 |
| MX2015002307A (es) | 2015-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211474A1 (en) | Treatment of immune-related and inflammatory diseases | |
| HK1211844A1 (en) | Treatment of pulmonary disease | |
| ZA201301601B (en) | Treatment of diseases | |
| HK1199015A1 (en) | Treatment of inflammation | |
| HK1211498A1 (en) | Treatment of sickle cell disease and inflammatory conditions | |
| HK1204573A1 (en) | Treatment of inflammatory skin disorders | |
| ZA201408059B (en) | Compositions and methods for the treatment of inflammatory bowel disease | |
| ES3014157T3 (en) | Novel methods and compositions for treatment of disease | |
| HK1211213A1 (en) | Treatment of diseases involving mucin | |
| ZA201500547B (en) | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases | |
| PL2892556T3 (pl) | Kompozycje i sposoby odnoszące się do leczenia chorób | |
| IL235874A0 (en) | Treatment of ocular inflammatory diseases by laquinimod | |
| EP2670438A4 (en) | SELECTION AND TREATMENT OF PATIENTS | |
| HK1200355A1 (en) | Treatment of red blood cells | |
| PT2928299T (pt) | Tratamento médico de doenças dérmicas inflamatórias crónicas com nor-cetotifeno | |
| EP2838521A4 (en) | FORMULATIONS AND METHODS FOR THE TREATMENT OF WOUNDS AND INFLAMMATORY SKIN DISORDERS | |
| IL223385B (en) | Treatment of inflammatory disorders | |
| GB201201778D0 (en) | Treatment of inflammatory respiratory disease | |
| GB201201779D0 (en) | Treatment of inflammatory disorders | |
| GB201204645D0 (en) | Treatment of disease | |
| GB201207431D0 (en) | Intravaginal treatment of gynacological conditions | |
| PL2870968T3 (pl) | Leczenie klinoptilolitem zapalnych chorób jelit | |
| GB201101770D0 (en) | Treatment of inflammatory respiratory disease | |
| AU2012902874A0 (en) | Treatment of inflammatory skin disorders | |
| GB201002842D0 (en) | Treatment of inflammatory disorders |